Upon knockdown of CD44, the glycoprotein carcinoembryonic antigen (CEA) acts as a compensatory mechanism to mediate colon cancer cell interactions with E‐selectin (Thomas et al, 2008). The gene discussed is CEACAM5; the disease is colonic neoplasm.